
Shionogi & Co Investor Relations Material
Latest events

Q4 2025
13 May, 2025

Q3 2025
31 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shionogi & Co Ltd
Access all reports
Shionogi & Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's core business areas include prescription drugs, over-the-counter medications, and diagnostic products. Shionogi focuses on therapeutic areas such as infectious diseases, pain management, and cardiovascular diseases. It also provides contract development and manufacturing services to other pharmaceutical companies. Shionogi & Co., Ltd. is headquartered in Osaka, Japan, and its shares are listed on the TYO.
Key slides for Shionogi & Co Ltd


Q3 2025
Shionogi & Co Ltd


Q2 2025
Shionogi & Co Ltd
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
4507
Country
🇯🇵 Japan